HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maximilian J Hochmair Selected Research

Maximilian J Hochmair Research Topics

Disease

31Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 08/2017
14Neoplasms (Cancer)
02/2024 - 11/2017
10Brain Neoplasms (Brain Tumor)
06/2022 - 08/2017
8Disease Progression
02/2024 - 08/2017
7Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2024 - 12/2018
7Lung Neoplasms (Lung Cancer)
04/2023 - 01/2017
3Neoplasm Metastasis (Metastasis)
02/2022 - 01/2017
2Adenocarcinoma of Lung
01/2021 - 01/2019
2Dyspnea (Shortness of Breath)
11/2020 - 11/2017
2Chest Pain (Chest Pains)
11/2020 - 01/2020
2Cough
11/2020 - 01/2020
1Circulating Neoplastic Cells
02/2024
1Pleural Effusion (Pleural Effusions)
01/2024
1Hypertension (High Blood Pressure)
04/2022
1Malignant Mesothelioma
04/2022
1Sarcopenia
02/2022
1Edema (Dropsy)
01/2022
1Febrile Neutropenia
01/2021
1Pneumonia (Pneumonitis)
01/2021
1Pulmonary Embolism
01/2021
1Dehydration (Water Stress)
01/2021
1Respiratory Insufficiency (Respiratory Failure)
01/2021
1Sudden Death
01/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Hepatitis
01/2021
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021
1Heart Arrest (Cardiac Arrest)
01/2021
1Sepsis (Septicemia)
01/2021
1Multiple Organ Failure (MODS)
01/2021
1Pancytopenia
01/2021
1Enterocolitis
01/2021
1Neutropenia
01/2021
1Fatigue
11/2020
1Weight Loss (Weight Reduction)
11/2017
1Clinical Deterioration
11/2017
1Adenocarcinoma
11/2017

Drug/Important Bio-Agent (IBA)

11PlatinumIBA
02/2024 - 05/2018
11osimertinibIBA
01/2022 - 01/2018
10Tyrosine Kinase InhibitorsIBA
04/2024 - 01/2017
9brigatinibIBA
12/2022 - 08/2017
7Etoposide (VP 16)FDA LinkGeneric
12/2023 - 12/2018
7CrizotinibIBA
12/2022 - 08/2017
7ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2019
7AfatinibIBA
01/2022 - 11/2018
6durvalumabIBA
02/2024 - 11/2019
6Anaplastic Lymphoma KinaseIBA
12/2022 - 08/2017
5Carboplatin (JM8)FDA LinkGeneric
12/2023 - 12/2018
5pembrolizumabIBA
10/2023 - 11/2017
4Biomarkers (Surrogate Marker)IBA
03/2024 - 02/2022
3DNA (Deoxyribonucleic Acid)IBA
05/2024 - 01/2018
3Pemetrexed (MTA)FDA Link
10/2023 - 01/2020
3Cisplatin (Platino)FDA LinkGeneric
10/2023 - 11/2020
3B7-H1 AntigenIBA
10/2020 - 05/2018
2atezolizumabIBA
12/2023 - 12/2018
2tremelimumabIBA
10/2023 - 01/2021
2Circulating Tumor DNAIBA
01/2021 - 01/2021
2lorlatinibIBA
11/2020 - 01/2017
1mobocertinibIBA
04/2024
1CytokinesIBA
01/2024
1Immune Checkpoint InhibitorsIBA
04/2023
1AsbestosIBA
04/2022
1capmatinibIBA
01/2022
1EnzymesIBA
01/2022
1CreatinineIBA
01/2022
1Cell-Free Nucleic AcidsIBA
01/2019

Therapy/Procedure

15Therapeutics
03/2024 - 01/2017
6Immunotherapy
03/2024 - 11/2017
6Drug Therapy (Chemotherapy)
04/2023 - 08/2017
3Time-to-Treatment
01/2022 - 09/2019
2Radiotherapy
06/2022 - 10/2018
1Cranial Irradiation
06/2022
1Combined Modality Therapy
04/2022
1Duration of Therapy
05/2020